Afya Limited (NASDAQ:AFYA – Get Free Report) VP Lelio De Souza Junior sold 36,204 shares of the stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $15.00, for a total value of $543,060.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Lelio De Souza Junior also recently made the following trade(s):
- On Friday, June 26th, Lelio De Souza Junior sold 41,541 shares of Afya stock. The shares were sold at an average price of $15.00, for a total value of $623,115.00.
- On Thursday, April 9th, Lelio De Souza Junior sold 16,279 shares of Afya stock. The stock was sold at an average price of $14.53, for a total transaction of $236,533.87.
- On Tuesday, April 7th, Lelio De Souza Junior sold 26,753 shares of Afya stock. The shares were sold at an average price of $14.95, for a total value of $399,957.35.
Afya Stock Down 2.6%
AFYA stock traded down $0.40 during mid-day trading on Monday, reaching $14.87. The company had a trading volume of 172,657 shares, compared to its average volume of 107,339. The company has a market capitalization of $1.39 billion, a price-to-earnings ratio of 9.72, a PEG ratio of 1.57 and a beta of 0.32. Afya Limited has a 52 week low of $13.00 and a 52 week high of $17.48. The stock has a 50 day simple moving average of $14.28 and a two-hundred day simple moving average of $14.54. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.78 and a quick ratio of 1.78.
Institutional Trading of Afya
Wall Street Analyst Weigh In
A number of brokerages recently commented on AFYA. Bank of America reaffirmed a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research note on Monday, April 20th. Zacks Research cut Afya from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 6th. JPMorgan Chase & Co. lowered their target price on shares of Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research note on Monday, June 22nd. Finally, Wall Street Zen downgraded Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 2nd. One analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Afya has an average rating of “Hold” and an average target price of $17.10.
Check Out Our Latest Stock Report on Afya
Afya Company Profile
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Featured Stories
- Five stocks we like better than Afya
- Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore
- As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
- KBR Insiders Are Buying While the Market Misreads Its Spinoff
- Contrarian Alert: 5 Downgraded Stocks That May Reward Long-Term Investors
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
